Roche coagulation test strips now OK
Roche Diagnostics has announced a resolution to a problem with its CoaguChek PT test strips, which were the subject of an Urgent Medical Device Correction issued last October after the strips showed random falsely high INR test results.
Roche Diagnostics has announced a resolution to a problem with its CoaguChek PT test strips, which were the subject of an Urgent Medical Device Correction issued last October after the strips showed random falsely high INR test results. At the time, the company recommended healthcare professionals duplicate the test to confirm the results and reduce the risk of inaccurate findings. Due to concerns that patient self-testers would not know how to conduct or interpret duplicate results, it was recommended that patients discontinue use of the strips. Now, practitioners can return to using a single test strip to monitor patients on anticoagulation therapy and self-testers may once again resume monitoring their INR levels with the CoaguChek PT strips. According to Roche, the problem stemmed from inadequate levels of thromboplastin on the test strip.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
Assessing Financial Impacts of Pharmacist-Led Interventions in Pediatric Ambulatory Care
December 5th 2023According to a poster abstract presented at the ASHP Midyear Clinical Meeting & Exhibition, specialty pharmacy services were used for a variety of conditions that have been reported in adult populations.
